Editorial: Cardiovascular and renal 2020: Cardiovascular protection by antidiabetic drugs: Key mechanisms and current clinical data.
作者信息
Gorr Matthew W, Wold Loren E
机构信息
Dorothy M. Davis Heart and Lung Research Institute, College of Medicine and College of Nursing, The Ohio State University, 1585 Neil Ave., Columbus, OH, 43210, USA.
Dorothy M. Davis Heart and Lung Research Institute, College of Medicine and College of Nursing, The Ohio State University, 1585 Neil Ave., Columbus, OH, 43210, USA.
出版信息
Curr Opin Pharmacol. 2020 Oct;54:vii-ix. doi: 10.1016/j.coph.2020.12.003.
Abstract
摘要
相似文献
1
Editorial: Cardiovascular and renal 2020: Cardiovascular protection by antidiabetic drugs: Key mechanisms and current clinical data.社论：心血管与肾脏2020：抗糖尿病药物对心血管的保护作用：关键机制与当前临床数据
Curr Opin Pharmacol. 2020 Oct;54:vii-ix. doi: 10.1016/j.coph.2020.12.003.
2
[Cardiovascular protection of patients with type 2 diabetes : from EMPA-REG OUTCOME to LEADER].2型糖尿病患者的心血管保护：从恩格列净心血管结局研究到利拉鲁肽心血管和降低死亡率研究
Rev Med Suisse. 2016 Aug 24;12(527):1370-1375.
3
Diabetes and hypertension: a comprehensive report on management and the prevention of cardiovascular and renal complications.糖尿病与高血压：关于管理及预防心血管和肾脏并发症的综合报告。
J Clin Hypertens (Greenwich). 2011 Apr;13(4):221-3. doi: 10.1111/j.1751-7176.2011.00453.x.
4
Spotlight on Antidiabetic Agents with Cardiovascular or Renoprotective Benefits.聚焦具有心血管或肾脏保护益处的抗糖尿病药物。
Perm J. 2018;22:18-034. doi: 10.7812/TPP/18-034.
5
Results from Cardiovascular Outcome Trials in Diabetes.糖尿病心血管结局试验的结果。
Endocrinol Nutr. 2016 Aug-Sep;63(7):317-9. doi: 10.1016/j.endonu.2016.04.001. Epub 2016 Jun 17.
6
SGLT2 inhibitors: hypotheses on the mechanism of cardiovascular protection.钠-葡萄糖协同转运蛋白2（SGLT2）抑制剂：心血管保护机制的假说
Lancet Diabetes Endocrinol. 2018 Jun;6(6):435-437. doi: 10.1016/S2213-8587(17)30314-5. Epub 2017 Oct 10.
7
Preventing Cardiovascular Disease in Patients With Diabetes: New Evidence Informs Changes in Standards of Care.
J Cardiovasc Nurs. 2016 May-Jun;31(3):198-200. doi: 10.1097/JCN.0000000000000333.
8
The reno-cardiovascular connection in the patient with Diabetes mellitus: What's new?
Endocrinol Diabetes Nutr. 2017 May;64(5):237-240. doi: 10.1016/j.endinu.2017.03.006. Epub 2017 Apr 26.
9
What to treat? The structural basis for renal and vascular complications and hypertension, and the role of angiotensin converting enzyme inhibition. Symposium, 26th meeting of the European Association for the Study of Diabetes. Dublin, Ireland, 10 September 1991.
J Hypertens Suppl. 1992 Apr;10(1):S1-53.
10
Guidelines for When to Consider Mortality-Reducing Treatments for Patients With Type 2 Diabetes Mellitus.
Am Fam Physician. 2022 Jan 1;105(1):93.
本文引用的文献
1
Metformin: still the sweet spot for CV protection in diabetes?二甲双胍：在糖尿病的心血管保护方面仍占据优势？
Curr Opin Pharmacol. 2020 Oct;54:202-208. doi: 10.1016/j.coph.2020.10.018. Epub 2020 Nov 30.
2
Renal protection with glucagon-like peptide-1 receptor agonists.胰高血糖素样肽-1 受体激动剂的肾脏保护作用。
Curr Opin Pharmacol. 2020 Oct;54:91-101. doi: 10.1016/j.coph.2020.08.018. Epub 2020 Oct 5.
3
Disruption of energy utilization in diabetic cardiomyopathy; a mini review.糖尿病心肌病中能量利用的紊乱；一篇综述。
Curr Opin Pharmacol. 2020 Oct;54:82-90. doi: 10.1016/j.coph.2020.08.015. Epub 2020 Sep 25.
4
Role of O-linked N-acetylglucosamine (O-GlcNAc) modification of proteins in diabetic cardiovascular complications.蛋白质的 O-连接 N-乙酰葡萄糖胺（O-GlcNAc）修饰在糖尿病心血管并发症中的作用。
Curr Opin Pharmacol. 2021 Apr;57:1-12. doi: 10.1016/j.coph.2020.08.005. Epub 2020 Sep 13.
5
Heart failure and diabetes: role of ATM.心力衰竭和糖尿病：ATM 的作用。
Curr Opin Pharmacol. 2020 Oct;54:27-35. doi: 10.1016/j.coph.2020.06.007. Epub 2020 Aug 1.
6
Diabetes, and its treatment, as an effector of autonomic nervous system circuits and its functions.糖尿病及其治疗作为自主神经系统回路及其功能的效应器。
Curr Opin Pharmacol. 2020 Oct;54:18-26. doi: 10.1016/j.coph.2020.06.006. Epub 2020 Jul 25.
7
Evolving understanding of cardiovascular protection by SGLT2 inhibitors: focus on renal protection, myocardial effects, uric acid, and magnesium balance.不断发展的 SGLT2 抑制剂对心血管保护作用的认识：关注肾脏保护、心肌效应、尿酸和镁平衡。
Curr Opin Pharmacol. 2020 Oct;54:11-17. doi: 10.1016/j.coph.2020.06.001. Epub 2020 Jul 15.
8
Mechanisms of diabetic cardiomyopathy and potential therapeutic strategies: preclinical and clinical evidence.糖尿病心肌病的发病机制及潜在治疗策略：临床前与临床证据。
Nat Rev Cardiol. 2020 Sep;17(9):585-607. doi: 10.1038/s41569-020-0339-2. Epub 2020 Feb 20.
9
Epidemiology of Obesity and Diabetes and Their Cardiovascular Complications.肥胖症、糖尿病及其心血管并发症的流行病学
Circ Res. 2016 May 27;118(11):1723-35. doi: 10.1161/CIRCRESAHA.115.306825.
Zotero 插件